Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Open-Label Extension in Advanced Parkinson's Disease
NCT00501969Phase 3Completed
- Sponsor
- UCB
- Start
- Aug 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Aug 2004; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00501969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501969.